Profile photo Kim van Loon

Kim van Loon

Assistant Professor - medical

Strategic program(s):

Research groups

Congenital heart disease

Research aim

To improve long term cardiovascular and neurodevelopmental outcome in patients with severe congenital heart disease.
Go to group

Congenital heart disease

Research aim

To improve long term cardiovascular and neurodevelopmental outcome in patients with severe congenital heart disease.
Go to group

Congenital esophageal and airway team utrecht

Research aim

Our research strives to improve outcomes for Esophageal Atresia patients, reducing morbidity and enhancing quality of life, while developing strategies for long-term improvement, shaping a brighter future.
Go to group

Perinatal surgery & brain damage

Research aim

Our mission is to unravel the impact of neonatal surgery, as well for congenital heart defects as non-cardiac anomalies on brain injury, development and long-term impairments to develop strategies to improve long-term outcome shaping a better future.
Go to group

Recent publications

Population Pharmacokinetics and Target Attainment of Allopurinol and Oxypurinol Before, During, and After Cardiac Surgery with Cardiopulmonary Bypass in Neonates with Critical Congenital Heart Disease Wan-Yu Chu, Maaike Nijman, Raymond Stegeman, Johannes M P J Breur, Nicolaas J G Jansen, Joppe Nijman, Kim van Loon, Erik Koomen, Karel Allegaert, Manon J N L Benders, Thomas P C Dorlo, Alwin D R Huitema,
Clinical Pharmacokinetics, 2024, vol. 63, p.1205-1220